Locations:
Search
Why definitive surgical closure is the gold standard, and new ways to make it possible
Cleveland Clinic’s new dedicated program offers nuanced care for a newly recognized cardiovascular risk factor
Why Cleveland Clinic is launching its cardioimmunology center
End-of-treatment VALOR-HCM analyses reassure on use in women, suggest disease-modifying potential
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New Cleveland Clinic data challenge traditional size thresholds for surgical intervention
Medical and surgical perspectives on current and emerging uses of ECMO and Impella
Cleveland Clinic pioneers a new paradigm in cardiovascular care delivery
Vigilance for symptom emergence matters, a large 20-year analysis reveals
Phase 3 ODYSSEY-HCM trial of mavacamten leaves lingering questions about potential broader use
‘Concise clinical guidance’ from ACC distills key advances in imaging and pharmacotherapy
Advertisement
Advertisement